நீரிழிவு கார்டியோமயோபதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நீரிழிவு கார்டியோமயோபதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நீரிழிவு கார்டியோமயோபதி Today - Breaking & Trending Today

Applied Therapeutics Announces Presentation of Data on the Prevalence of Diabetic ...

Applied Therapeutics Announces Presentation of Data on the Prevalence of Diabetic ...
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Riccardo Perfetti , Maghan Meyers , Shoshana Shendelman , University Of California San Diego Medical Center , American Diabetes Association , Exchange Commission , Prognostic Implications Of Diabetic Cardiomyopathy In Community , Therapeutics Inc , Diabetic Cardiomyopathy , Applied Therapeutics , Scientific Sessions , Diabetes Association , Optimal Screening Approaches , Prognostic Implications , Community Dwelling Adults , Heart Failure , California San Diego Medical Center , Left Atrial Enlargement , Chief Medical Officer , Chief Executive Officer , Aldose Reductase , Aldose Reductase Inhibitor , Private Securities Litigation Reform Act , Galactosemia Kids ,

Applied Therapeutics Announces Presentation of Data on the

Applied Therapeutics Announces Presentation of Data on the
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Riccardo Perfetti , Shoshana Shendelman , University Of California San Diego Medical Center , American Diabetes Association , Exchange Commission , Prognostic Implications Of Diabetic Cardiomyopathy In Community , Therapeutics Inc , Diabetic Cardiomyopathy , Applied Therapeutics , Scientific Sessions , Diabetes Association , Optimal Screening Approaches , Prognostic Implications , Community Dwelling Adults , Heart Failure , California San Diego Medical Center , Left Atrial Enlargement , Chief Medical Officer , Chief Executive Officer , Aldose Reductase , Aldose Reductase Inhibitor , Private Securities Litigation Reform Act , Galactosemia Kids , ஒன்றுபட்டது மாநிலங்களில் ,

Applied Therapeutics to Present Cross-Sectional Analysis of Galactosemia Disease Progression at 2021 Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics

Published: Apr 07, 2021
NEW YORK, April 07, 2021 (GLOBE NEWSWIRE)
Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced a poster presentation at the upcoming 2021 Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics (ACMG) taking place April 13-16, 2021. The abstract and presentation include a cross-sectional analysis of nineteen pediatric patients with Classic Galactosemia, characterizing progressive worsening of the central nervous system (CNS) phenotype with age.
“We are pleased to share this important data with the medical community,” said Riccardo Perfetti, MD, PhD, Chief Medical Officer of Applied Therapeutics. “The severity and significant decline in CNS outcomes with age underscores the urgency for a disease-modifying therapy to halt or pre ....

Riccardo Perfetti , Maeve Conneighton , Therapeutics Inc , Clinical Genetics Meeting , American College , Medical Genetics , Classic Galactosemia , Chief Medical Officer , Progressive Worsening , Central Nervous System Phenotype , Diabetic Cardiomyopathy , ரிக்கார்டோ பேர்பேத்தி , சிகிச்சை இன்க் , மருத்துவ ஜெநெடிக்ஸ் சந்தித்தல் , அமெரிக்கன் கல்லூரி , மருத்துவ ஜெநெடிக்ஸ் , தலைமை மருத்துவ அதிகாரி , நீரிழிவு கார்டியோமயோபதி ,

Applied Therapeutics to Host Virtual Rare Disease Forum - Mar 16, 2021

Published: Mar 16, 2021
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE)
Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it will host a Virtual Rare Disease Forum on Tuesday, March 23
rd, 2021 from 1:00pm to 3:00pm ET. The event will highlight Applied Therapeutics’ development programs in Galactosemia, SORD Deficiency, and PMM2-CDG. The agenda for the event will include:
Update on ACTION-Galactosemia Clinical Development Program
Overview of SORD Deficiency, presented by Stephan L. Züchner, MD, PhD, Professor and Department Chair of Human Genetics at the University of Miami Miller School of Medicine ....

United States , Joseph Muenzer , Maeve Conneighton , Shoshana Shendelman , University Of North Carolina Children Research Institute , Clinical Development Program , Virtual Rare Disease Forum On , University Of Miami Miller School Medicine , Deficiency Clinical Development , Therapeutics Inc , Virtual Rare Disease Forum , Applied Therapeutic , Galactosemia Clinical Development , Department Chair , Human Genetics , Miami Miller School , Clinical Development , Pediatric Genetics , North Carolina Children , Development Program , Diabetic Cardiomyopathy , Applied Therapeutics To Host Virtual Rare Disease Forum Mar 16 , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினா குழந்தைகள் ஆராய்ச்சி நிறுவனம் , மருத்துவ வளர்ச்சி ப்ரோக்ர்யாம் , மெய்நிகர் ரேர் நோய் மன்றம் ஆன் ,

Applied Therapeutics to Host Virtual Rare Disease Forum

Applied Therapeutics to Host Virtual Rare Disease Forum
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Joseph Muenzer , Maeve Conneighton , Shoshana Shendelman , University Of North Carolina Children Research Institute , Clinical Development Program , Virtual Rare Disease Forum On , University Of Miami Miller School Medicine , Deficiency Clinical Development , Therapeutics Inc , Virtual Rare Disease Forum , Applied Therapeutic , Galactosemia Clinical Development , Department Chair , Human Genetics , Miami Miller School , Clinical Development , Pediatric Genetics , North Carolina Children , Development Program , Diabetic Cardiomyopathy , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினா குழந்தைகள் ஆராய்ச்சி நிறுவனம் , மருத்துவ வளர்ச்சி ப்ரோக்ர்யாம் , மெய்நிகர் ரேர் நோய் மன்றம் ஆன் , பல்கலைக்கழகம் ஆஃப் மியாமி மில்லர் பள்ளி மருந்து ,